Tarsus Pharmaceuticals Ownership | Who Owns Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals Ownership Summary
Tarsus Pharmaceuticals is owned by 110.71% institutional investors, 3.23% insiders. Blackrock is the largest institutional shareholder, holding 9.25% of TARS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Tarsus Pharmaceuticals shares.
TARS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tarsus Pharmaceuticals | 110.71% | 3.23% | -13.94% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 3.27M | 9.25% | $88.79M |
| Blackrock funding, inc. /de | 3.79M | 8.95% | $153.62M |
| Rtw investments, lp | 3.11M | 7.35% | $126.05M |
| Paradigm biocapital advisors lp | 2.53M | 6.60% | $140.19M |
| Cowen and company | 2.20M | 6.22% | $59.72M |
| Jennison associates | 2.47M | 5.83% | $99.98M |
| Tang capital management | 2.45M | 5.79% | $99.44M |
| Vanguard group | 2.12M | 5.51% | $117.12M |
| Morgan stanley | 1.88M | 5.34% | $51.23M |
| Deep track capital, lp | 1.75M | 4.13% | $70.89M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 2.45M | 5.03% | $99.44M |
| Paradigm biocapital advisors lp | 2.53M | 4.88% | $140.19M |
| Ally bridge group (ny) | 121.18K | 4.08% | $4.91M |
| Tfg asset management gp | 200.00K | 2.73% | $11.07M |
| Cutter capital management, lp | 112.50K | 2.55% | $6.23M |
| Bioimpact capital | 341.50K | 2.40% | $13.83M |
| Deep track capital, lp | 1.75M | 2.27% | $70.89M |
| Frazier life sciences management | 1.40M | 2.26% | $56.61M |
| Ghost tree capital | 235.00K | 2.00% | $6.39M |
| Rtw investments, lp | 3.11M | 1.80% | $126.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 3.79M | 0.00% | 638.46K |
| Blackrock | 3.27M | 0.00% | 614.03K |
| Millennium management | 644.01K | 0.02% | 421.50K |
| Bioimpact capital | 341.50K | 2.40% | 341.50K |
| Deep track capital, lp | 1.75M | 2.27% | 265.73K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Exoduspoint capital management, lp | - | - | -883.04K |
| Toronto dominion bank | 1.00M | 0.07% | -872.78K |
| Vivo capital | - | - | -565.55K |
| Morgan stanley | 1.88M | 0.00% | -514.23K |
| Orbimed advisors | 197.90K | 0.20% | -455.84K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bioimpact capital | 341.50K | 2.40% | 341.50K | $13.83M |
| Capitolis liquid global markets | 242.10K | 0.07% | 242.10K | $9.81M |
| Caption management | 160.00K | 0.07% | 160.00K | $4.35M |
| Cutter capital management, lp | 112.50K | 2.55% | 112.50K | $6.23M |
| Pdt partners | 63.03K | 0.14% | 63.03K | $2.55M |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -5.00 |
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Stephens consulting | -10.00 |
| Riggs asset managment | -10.00 |
| Amundi | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 193 | -3.02% | 43,559,205 | 8.22% | 110 | 1.01% | 100 | -16.67% | 71 | 29.09% |
| Dec 31, 2024 | 62 | -63.10% | 11,285,757 | -73.99% | 29 | 0.23% | 40 | -58.33% | 14 | -68.18% |
| Sep 30, 2024 | 168 | 9.80% | 43,393,921 | 8.30% | 113 | 0.88% | 96 | 2.13% | 44 | 2.33% |
| Jun 30, 2024 | 153 | -6.71% | 40,069,329 | 2.31% | 113 | 0.92% | 94 | -9.62% | 43 | 34.38% |
| Mar 31, 2024 | 164 | 35.54% | 39,163,544 | 21.70% | 110 | 0.92% | 104 | 38.67% | 32 | 28.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.19M | 2.82% | -24.83K |
| Vanguard US Total Market Shares ETF | 1.14M | 2.73% | - |
| iShares Russell 2000 ETF | 912.96K | 2.16% | -17.32K |
| Jennison SMid Cap Core Equity | 682.75K | 1.63% | 17.89K |
| PGIM Jennison Small Company A | 682.75K | 1.62% | 1.95K |
| AZ InvestEd Ivy Small Cap Growth E | 551.28K | 1.31% | 22.32K |
| Macquarie Small Cap Growth C | 551.28K | 1.31% | 22.32K |
| MEDICAL BioHealth EUR Acc | 527.77K | 1.26% | 87.59K |
| Invesco Small Cap Value A | 457.84K | 1.09% | -51.75K |
| Vanguard Institutional Extnd Mkt Idx Tr | 413.47K | 0.98% | -181.14K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 11, 2025 | Azamian Bobak R. | President/CEO and Board Chair | Sell | $300.00K |
| Jun 17, 2025 | Farrow Jeffrey S | See Remarks | Sell | $550.04K |
| Jun 16, 2025 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | $41.33K |
| Jun 09, 2025 | Mottiwala Aziz | Chief Commercial Officer | Sell | $765.80K |
| Mar 24, 2025 | Azamian Bobak R. | President/CEO and Board Chair | Sell | $300.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | - | 19 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 2 |
TARS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools